Logo-ps

Editorial Policies

Policies on Human and Animal Rights and Informed Consent

Pharmaceutical Sciences endorse the guidelines of the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions, the Council of Science Editors’ White Paper on Promoting Integrity in Scientific Journal Publications and the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.

In cases where a study involves the use of live animals or human subjects, the author should include a statement that all experiments were performed in compliance with the relevant laws and institutional guidelines, and also state the institutional committee(s) that has approved the experiments. They should also include a statement that informed consent was obtained for any experimentation with human subjects.

For more information on ethical considerations, see our publisher's Editorial policy.

Policies on Conflict of Interest

All authors must declare all competing interests in their covering letter and in the “competing interests” section upon submission. Where authors have no competing interests, the statement should read “The author(s) declare(s) that they have no competing interests with regards to authorship and/or publication of this article.” The Editor may ask for further information relating to competing interests.

Reviewers of Pharmaceutical Sciences are also required to declare any competing interests and they will be excluded from the peer review process if a competing interest exists.

Editors and advisory board of Pharmaceutical Sciences declare no competing interests and any financial relationship with any biomedical company and they were excluded from peer review process whenever submitting a manuscript to the journal.

Data Sharing

Pharmaceutical Sciences encourages authors to share the data and any other material associated with methodology and the results of the submitted articles, in an appropriate public repository, or as open access supplementary to the article. In line with ICMJE recommendations, a data sharing statement is required for manuscripts reporting the results of clinical trials, on whether and how the data will be available. For more information, please consult ICMJE recommendations (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial registration.html#two)

For more information about other policies, see our publisher's Editorial policy


Indexing & Abstracting:

 

CiteScore (2019): 1.7
SJR (2019): 0.252
SNIP (2019): 0.703

  SCImago Journal & Country Rank

 

Follower of ICMJE

Follower of COPE

Powered by:

Director-in-Charge:
Dr. Mohammad Reza Siahi

Editor-in-Chief:
 
Dr. Alireza Garjani